Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 1
2001 1
2005 1
2006 1
2008 2
2009 3
2011 1
2013 1
2014 2
2015 3
2016 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Individual trajectory-based care for COPD: getting closer, but not there yet.
Roche N, Devillier P, Berger P, Bourdin A, Dusser D, Muir JF, Martinat Y, Terrioux P, Housset B. Roche N, et al. Among authors: dusser d. ERJ Open Res. 2021 Dec 13;7(4):00451-2021. doi: 10.1183/23120541.00451-2021. eCollection 2021 Oct. ERJ Open Res. 2021. PMID: 34912881 Free PMC article. Review.
Several comorbidities are known to impact symptoms, physical and social activity and lung function. The possible long-term side-effects of inhaled corticosteroids contrasting with their over-prescription in COPD patients justify the regular assessment of their benefits and …
Several comorbidities are known to impact symptoms, physical and social activity and lung function. The possible long-term side-effec …
Update on the roles of distal airways in asthma.
Burgel PR, de Blic J, Chanez P, Delacourt C, Devillier P, Didier A, Dubus JC, Frachon I, Garcia G, Humbert M, Laurent F, Louis R, Magnan A, Mahut B, Perez T, Roche N, Tillie-Leblond I, Tunon de Lara M, Dusser D. Burgel PR, et al. Among authors: dusser d. Eur Respir Rev. 2009 Jun;18(112):80-95. doi: 10.1183/09059180.00001109. Eur Respir Rev. 2009. PMID: 20956128 Free article. Review.
Extra-fine aerosols of long-acting beta-agonists, inhaled corticosteroids or inhaled corticosteroid/long-acting beta-agonist combinations have been shown in short-term studies to be not inferior to non-extra-fine aerosols of comparators. ...
Extra-fine aerosols of long-acting beta-agonists, inhaled corticosteroids or inhaled corticosteroid/long-acting beta-agonist combinations ha …
Long-term management of reversible obstructive airways disease in adults.
Lurie A, Vlastos FD, Dusser DJ, Strauch G, Marsac J. Lurie A, et al. Among authors: dusser dj. Lung. 1990;168 Suppl:154-67. doi: 10.1007/BF02718128. Lung. 1990. PMID: 1974671 Review.
The goals of the long-term management of reversible obstructive airways disease (ROAD) are to find the minimum treatment that controls symptoms, allows resumption of normal life, prevents severe attack and death, and controls airflow obstruction. ...
The goals of the long-term management of reversible obstructive airways disease (ROAD) are to find the minimum treatment that control …
[Prevention of chronic obstructive pulmonary disease exacerbations].
Dusser D. Dusser D. Presse Med. 2008 Nov;37(11):1604-8. doi: 10.1016/j.lpm.2008.08.003. Epub 2008 Sep 30. Presse Med. 2008. PMID: 18829252 Review. French.
Important nonpharmacologic therapies that directly decrease the risk of exacerbation or hospitalization include smoking cessation, oxygen therapy, pulmonary rehabilitation, and education. Most of the drugs available for long-term management of COPD have significant effects …
Important nonpharmacologic therapies that directly decrease the risk of exacerbation or hospitalization include smoking cessation, oxygen th …
[Treatments targeting distal airways in asthma: update on clinical studies].
Burgel PR, Frachon I, Didier A, Dusser D. Burgel PR, et al. Among authors: dusser d. Rev Mal Respir. 2009 Oct;26(8):859-66. doi: 10.1016/s0761-8425(09)73681-2. Rev Mal Respir. 2009. PMID: 19953030 Review. French.
With the exception of a few studies, most publications have been performed in a limited number of patients and for only short durations. The available studies have not yet demonstrated a long-term benefit in terms of additional clinical efficacy of these ultrafine inhaled …
With the exception of a few studies, most publications have been performed in a limited number of patients and for only short durations. The …
The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes.
Anzueto A, Wise R, Calverley P, Dusser D, Tang W, Metzdorf N, Dahl R. Anzueto A, et al. Among authors: dusser d. Respir Res. 2015 Sep 15;16(1):107. doi: 10.1186/s12931-015-0269-4. Respir Res. 2015. PMID: 26369563 Free PMC article. Clinical Trial.
A prespecified spirometry substudy compared the lung function efficacy between treatment groups. METHODS: TIOSPIR was a large-scale, long-term (2.3-year), event-driven, randomized, double-blind, parallel-group trial of 17,135 patients with COPD. ...
A prespecified spirometry substudy compared the lung function efficacy between treatment groups. METHODS: TIOSPIR was a large-scale, long- …
DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Viel M, Hubert D, Burgel PR, Génin E, Honoré I, Martinez B, Gaitch N, Chapron J, Kanaan R, Dusser D, Girodon E, Bienvenu T. Viel M, et al. Among authors: dusser d. Clin Respir J. 2016 Nov;10(6):777-783. doi: 10.1111/crj.12288. Epub 2015 Apr 15. Clin Respir J. 2016. PMID: 25763772
BACKGROUND AND AIMS: Pseudomonas aeruginosa (Pa) infection in cystic fibrosis (CF) patients is associated with worse long-term pulmonary disease and shorter survival, and chronic Pa infection (CPA) is associated with reduced lung function, faster rate of lung decline, incr …
BACKGROUND AND AIMS: Pseudomonas aeruginosa (Pa) infection in cystic fibrosis (CF) patients is associated with worse long-term pulmon …
Poor survival in rheumatoid arthritis associated with bronchiectasis: a family-based cohort study.
Puéchal X, Génin E, Bienvenu T, Le Jeunne C, Dusser DJ. Puéchal X, et al. Among authors: dusser dj. PLoS One. 2014 Oct 13;9(10):e110066. doi: 10.1371/journal.pone.0110066. eCollection 2014. PLoS One. 2014. PMID: 25310716 Free PMC article.
CFTR (cystic fibrosis transmembrane conductance regulator) mutations predispose RA patients to DB, but the prognosis of RA-associated DB (RA-DB) is unclear. METHODS: We report long-term mortality data from a nationwide family-based association study of patients with RA onl …
CFTR (cystic fibrosis transmembrane conductance regulator) mutations predispose RA patients to DB, but the prognosis of RA-associated DB (RA …
Clinical characteristics and prognostic factors of pulmonary MALT lymphoma.
Borie R, Wislez M, Thabut G, Antoine M, Rabbat A, Couderc LJ, Monnet I, Nunes H, Blanc FX, Mal H, Bergeron A, Dusser D, Israël-Biet D, Crestani B, Cadranel J. Borie R, et al. Among authors: dusser d. Eur Respir J. 2009 Dec;34(6):1408-16. doi: 10.1183/09031936.00039309. Epub 2009 Jun 18. Eur Respir J. 2009. PMID: 19541720 Free article.
Our objective was to evaluate the initial extent of disease and to analyse the characteristics and long-term outcome of these patients. All chest and pathological departments of teaching hospitals in Paris were contacted in order to identify patients with a histological di …
Our objective was to evaluate the initial extent of disease and to analyse the characteristics and long-term outcome of these patient …
19 results